Mochida Pharmaceutical Co., Ltd. logo

Mochida Pharmaceutical Co., Ltd.

4534.T

JPXHealthcareDrug Manufacturers - Specialty & Generic

Latest quote

¥3,265

+¥5.00 · +0.15%

Aug 24, 3:30 PM JST

4534.T company overview

Regular session · JST · Market data may be delayed.

Company profile

Company website

Established in 1913 and headquartered in Tokyo, Japan, Mochida Pharmaceutical Co., Ltd. specializes in the development, manufacturing, and distribution of a wide array of medical and personal care products. Its primary offerings encompass pharmaceuticals, diagnostic solutions, and skincare lines. The company's extensive pharmaceutical portfolio includes treatments for a variety of conditions, such as cardiovascular issues, pain (analgesics), gastrointestinal ailments, neurological disorders, infections (anti-infectives), diabetes (antidiabetics), and cancer (oncological agents). Additionally, it provides hormone and biological preparations, alongside biosimilars, catering to therapeutic areas like dermatology, psychiatry, obstetrics, and gynecology. In diagnostics, Mochida produces various reagents, particularly those utilized for fertility and infertility assessments. Its skincare division features products designed for facial, body, and hair care. Beyond its existing product range, Mochida Pharmaceutical actively invests in research and development, with a specific focus on creating therapies for intractable diseases. The company has also forged strategic collaborations, including a partnership with Amarin Corporation plc for the advancement and market introduction of ethyl icosapentate products. Furthermore, it collaborates with Gene Techno Science Co., Ltd. to innovate regenerative medicine targeting rare and challenging digestive disorders, such as congenital isolated hypoganglionosis.

Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
Headquarters
JP
CEO
Naoyuki Mochida
Listed since
Jan 1, 2001
Employees
1,479

Market position

Day range

Current ¥3,265

52-week range

Current ¥3,265

Open
¥3,285
Previous close
¥3,260
Volume
35K
0.34× average
Average volume
102.19K
Average daily volume
Market cap
115.43B JPY
Beta
0.36
Market reference 1
50-day average
¥3,169
+3.03% above average
200-day average
¥3,422.03
-4.59% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
104.59B JPY
P/E (TTM)
12.59×
P/B (TTM)
0.82×
P/S (TTM)
0.95×
EV / EBITDA
7.97×
Earnings yield
6.44%
Free cash flow yield
-8.19%
Dividend yield
2.45%

Profitability & efficiency

Gross margin
46.97%
Operating margin
9.13%
Net margin
7.53%
Return on equity
5.63%
Return on assets
4.33%
Return on invested capital
4.63%

Financial health

Debt / equity
0.08×
Current ratio
4.29×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends59%39%19%-1%Gross margin, FY2021: 54.05%Gross margin, FY2022: 53.37%Gross margin, FY2023: 50.61%Gross margin, FY2024: 51.15%Gross margin, FY2025: 48.11%Operating margin, FY2021: 13.06%Operating margin, FY2022: 8.24%Operating margin, FY2023: 5.64%Operating margin, FY2024: 7.73%Operating margin, FY2025: 8.68%Net margin, FY2021: 9.59%Net margin, FY2022: 6.44%Net margin, FY2023: 4.42%Net margin, FY2024: 5.41%Net margin, FY2025: 6.76%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 54.05%. Gross margin FY2022 53.37%. Gross margin FY2023 50.61%. Gross margin FY2024 51.15%. Gross margin FY2025 48.11%. Operating margin FY2021 13.06%. Operating margin FY2022 8.24%. Operating margin FY2023 5.64%. Operating margin FY2024 7.73%. Operating margin FY2025 8.68%. Net margin FY2021 9.59%. Net margin FY2022 6.44%. Net margin FY2023 4.42%. Net margin FY2024 5.41%. Net margin FY2025 6.76%.

Income trends

Revenue

116.95B JPY+11.21%

Operating income

10.15B JPY+24.87%

Net income

7.9B JPY+39.01%
Income trends across reported periods128.19B JPY83.23B JPY38.27B JPY−6.69B JPYRevenue, FY2021: 110.18B JPYRevenue, FY2022: 103.26B JPYRevenue, FY2023: 102.89B JPYRevenue, FY2024: 105.16B JPYRevenue, FY2025: 116.95B JPYOperating income, FY2021: 14.39B JPYOperating income, FY2022: 8.51B JPYOperating income, FY2023: 5.8B JPYOperating income, FY2024: 8.13B JPYOperating income, FY2025: 10.15B JPYNet income, FY2021: 10.57B JPYNet income, FY2022: 6.65B JPYNet income, FY2023: 4.55B JPYNet income, FY2024: 5.69B JPYNet income, FY2025: 7.9B JPYFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 110.18B JPY. Revenue FY2022 103.26B JPY. Revenue FY2023 102.89B JPY. Revenue FY2024 105.16B JPY. Revenue FY2025 116.95B JPY. Operating income FY2021 14.39B JPY. Operating income FY2022 8.51B JPY. Operating income FY2023 5.8B JPY. Operating income FY2024 8.13B JPY. Operating income FY2025 10.15B JPY. Net income FY2021 10.57B JPY. Net income FY2022 6.65B JPY. Net income FY2023 4.55B JPY. Net income FY2024 5.69B JPY. Net income FY2025 7.9B JPY.
Metric (JPY)FY2025FY2024FY2023FY2022FY2021
Revenue116.95B JPY105.16B JPY102.89B JPY103.26B JPY110.18B JPY
Cost of goods sold60.69B JPY51.37B JPY50.82B JPY48.15B JPY50.63B JPY
Gross profit56.26B JPY53.79B JPY52.07B JPY55.12B JPY59.55B JPY
Research and development11.68B JPY12.55B JPY13.28B JPY12.3B JPY
Selling, general, and administrative46.11B JPY33.99B JPY33.71B JPY33.32B JPY32.87B JPY
Operating expenses46.11B JPY45.66B JPY46.27B JPY46.61B JPY45.16B JPY
Interest income112M JPY29M JPY2M JPY2M JPY2M JPY
Interest expense72M JPY3M JPY2M JPY
Depreciation and amortization2.98B JPY2.94B JPY2.81B JPY2.67B JPY2.69B JPY
Operating income10.15B JPY8.13B JPY5.8B JPY8.51B JPY14.39B JPY
Net income7.9B JPY5.69B JPY4.55B JPY6.65B JPY10.57B JPY

Company facts updated Aug 24, 2026.

Earnings

Latest EPS result
89.75

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly EPS actual values compared with estimates96.7565.1433.531.91Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Q4 2024, reported Nov 1, 2024: actual 35.85, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Feb 7, 2025: actual 78.4, estimate —, surprise —, Comparison unavailable. Q2 2025, reported May 12, 2025: actual 2.25, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 1, 2025: actual 53.43, estimate —, surprise —, Comparison unavailable. Q4 2025, reported Oct 30, 2025: actual 55.36, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Feb 6, 2026: actual 70.12, estimate —, surprise —, Comparison unavailable. Q2 2026, reported May 15, 2026: actual 44.05, estimate —, surprise —, Comparison unavailable. Q3 2026, reported Aug 3, 2026: actual 89.75, estimate —, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly Revenue actual values compared with estimates33.8B30.24B26.69B23.13BQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Q4 2024, reported Nov 1, 2024: actual 25.69B JPY, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Feb 7, 2025: actual 29.64B JPY, estimate —, surprise —, Comparison unavailable. Q2 2025, reported May 12, 2025: actual 24.43B JPY, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 1, 2025: actual 26.63B JPY, estimate —, surprise —, Comparison unavailable. Q4 2025, reported Oct 30, 2025: actual 28.35B JPY, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Feb 6, 2026: actual 32.5B JPY, estimate —, surprise —, Comparison unavailable. Q2 2026, reported May 15, 2026: actual 29.46B JPY, estimate —, surprise —, Comparison unavailable. Q3 2026, reported Aug 3, 2026: actual 31.72B JPY, estimate —, surprise —, Comparison unavailable.

Corporate actions

Annual dividends per share

Cash distributions grouped by calendar year; partial years are marked.

¥80.00

2025 complete year0.0% since 2021

2026 partial: ¥40.00

* Partial calendar year in the available dividend history.

Corporate action history

DividendUpcoming

Ex-dividend Sep 29, 2026

¥42.50

Semi-Annual

Record Sep 30, 2026 · Payment Sep 29, 2026

DividendUpcoming

Ex-dividend Mar 30, 2027

¥42.50

Semi-Annual

Record Mar 31, 2027 · Payment Mar 30, 2027

Dividend

Ex-dividend Mar 30, 2026

¥40.00

Semi-Annual

Record Mar 31, 2026 · Payment Jun 26, 2026

Dividend

Ex-dividend Sep 29, 2025

¥40.00

Semi-Annual

Record Sep 30, 2025 · Payment Dec 1, 2025

Dividend

Ex-dividend Mar 28, 2025

¥40.00

Semi-Annual

Record Mar 31, 2025 · Payment Jun 30, 2025

Dividend

Ex-dividend Sep 27, 2024

¥40.00

Semi-Annual

Record Sep 30, 2024 · Payment Dec 2, 2024

4534.T peers

ETFs holding 4534.T

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research 4534.T

research.disclaimer